Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
10.10
-0.07 (-0.74%)
Mar 24, 2026, 10:42 AM EDT - Market open
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $622.58 million as of March 24, 2026. Its market cap has increased by 123.49% in one year.
Market Cap
622.58M
Enterprise Value
408.90M
1-Year Change
123.49%
Ranking
Category
Stock Price
$10.10
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $622.58M, a decrease of -71.78%. That is a compound annual growth rate of -22.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 627.21M | 17.38% |
| Dec 31, 2025 | 534.32M | 52.95% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
| Mar 26, 2021 | 2.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ocugen | 668.91M |
| Lexicon Pharmaceuticals | 660.94M |
| Gyre Therapeutics | 651.60M |
| Eikon Therapeutics | 638.09M |
| Relmada Therapeutics | 636.68M |
| Prime Medicine | 635.54M |
| Alpha Tau Medical | 622.23M |
| MiMedx Group | 612.09M |